00038sek
0,0 %
Date:2024-04-26Time:17:29:00Latest report:Q4-2023List:First NorthTicker:AMNI
Market Cap:10 msekEnterprise Value:2 msekNet Sales:- msekEarnings:-30,9 msekEmployees:0ISIN:SE0015961016

Ratios

10-year key figure history for Amniotics turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Amniotics with index and moving average MA50 and MA200.

Stockprice:0,0038
MA50:0,00
MA200:0,03
Price/MA200:-86,1 %
RSI (14):50,4
Price/MA50:2,3 %

Description

Amniotics is a biopharmaceutical company that, based on amniotic fluid, extracts high-quality stem cell products and surfactant, and with these develops effective treatments for specific diseases and conditions. Amniotics has developed and controlled the entire process, from extraction of amniotic fluid with a patented medical device to sorting and propagating cells, as well as production of ampoules with mesenchymal stem cells (MSC) for use as cell therapy.

Pharmaceuticals